ArticleJournal for immunotherapy of cancer2022

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer.

Jacob P van Vloten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.